• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭示双重威胁:肌肉减少症和身体活动不足对糖尿病风险的影响

Unraveling the dual threat: sarcopenia and insufficient physical activity in diabetes risk.

作者信息

Shi Hui

机构信息

Department of Clinical Nutrition, Zibo First Hospital, Zibo, China.

出版信息

Front Endocrinol (Lausanne). 2025 Jan 8;15:1507657. doi: 10.3389/fendo.2024.1507657. eCollection 2024.

DOI:10.3389/fendo.2024.1507657
PMID:39845879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11750674/
Abstract

PURPOSE

This study aimed to investigate the alterations in diabetes risk associated with sarcopenia and insufficient physical activity, as well as the demographic shifts within the diabetic population.

METHOD

Utilizing pertinent data from the National Health and Nutrition Examination Survey (NHANES) database spanning 2011 to 2018, the criteria for sarcopenia were established by the Foundation for the National Institutes of Health. These criteria were calculated using lean body mass data in conjunction with body mass index data. Physical activity levels were assessed using the PAQ questionnaire from the NHANES database. The presence of diabetes was determined through the DIQ questionnaire and the laboratory examination within the NHANES database. The analysis was performed using multivariable logistic regression.

RESULT

The prevalence of both sarcopenia and insufficient physical activity in the diabetic population was 188% greater than in the non-diabetic population. Sarcopenia and insufficient physical activity were positively correlated with an increased risk of diabetes onset, demonstrating a 1.45-fold heightened risk when both conditions were present (OR=2.45,95%CI,1.35-4.44,P<0.05). This combined effect was significantly greater than the risk associated with sarcopenia alone (OR=1.84,95%CI,1.09-3.11,P<0.05) or insufficient physical activity alone (OR=1.55,95%CI,1.11-2.15,P<0.05).

CONCLUSION

A synergistic relationship exists between sarcopenia and insufficient physical activity, resulting in a markedly elevated risk of diabetes when both conditions are present concurrently. Therefore, comprehensive diabetes management strategies should prioritize populations exhibiting both sarcopenia and insufficient physical activity.

摘要

目的

本研究旨在调查与肌肉减少症和身体活动不足相关的糖尿病风险变化,以及糖尿病患者群体中的人口统计学变化。

方法

利用2011年至2018年美国国家健康与营养检查调查(NHANES)数据库中的相关数据,美国国立卫生研究院基金会制定了肌肉减少症的标准。这些标准是结合瘦体重数据和体重指数数据计算得出的。身体活动水平使用NHANES数据库中的PAQ问卷进行评估。糖尿病的存在通过NHANES数据库中的DIQ问卷和实验室检查来确定。分析采用多变量逻辑回归进行。

结果

糖尿病患者群体中肌肉减少症和身体活动不足的患病率比非糖尿病患者群体高188%。肌肉减少症和身体活动不足与糖尿病发病风险增加呈正相关,当两种情况同时存在时,风险增加1.45倍(OR=2.45,95%CI,1.35-4.44,P<0.05)。这种联合效应显著大于单独与肌肉减少症相关的风险(OR=1.84,95%CI,1.09-3.11,P<0.05)或单独与身体活动不足相关的风险(OR=1.55,95%CI,1.11-2.15,P<0.05)。

结论

肌肉减少症和身体活动不足之间存在协同关系,当两种情况同时存在时,糖尿病风险会显著升高。因此,全面的糖尿病管理策略应优先考虑同时表现出肌肉减少症和身体活动不足的人群。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d294/11750674/e721c7b9f218/fendo-15-1507657-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d294/11750674/8ec110a5d411/fendo-15-1507657-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d294/11750674/431871935655/fendo-15-1507657-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d294/11750674/e721c7b9f218/fendo-15-1507657-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d294/11750674/8ec110a5d411/fendo-15-1507657-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d294/11750674/431871935655/fendo-15-1507657-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d294/11750674/e721c7b9f218/fendo-15-1507657-g003.jpg

相似文献

1
Unraveling the dual threat: sarcopenia and insufficient physical activity in diabetes risk.揭示双重威胁:肌肉减少症和身体活动不足对糖尿病风险的影响
Front Endocrinol (Lausanne). 2025 Jan 8;15:1507657. doi: 10.3389/fendo.2024.1507657. eCollection 2024.
2
Associations of muscle mass, strength, and quality with diabetes and the mediating role of inflammation in two National surveys from China and the United states.肌肉量、力量和质量与糖尿病的关联,以及炎症在中国和美国的两项全国性调查中的中介作用。
Diabetes Res Clin Pract. 2024 Aug;214:111783. doi: 10.1016/j.diabres.2024.111783. Epub 2024 Jul 11.
3
Correlation and predictive value of novel anthropometric indicators with adult sarcopenia and sarcopenia obesity.新型人体测量指标与成人肌少症及肌少症肥胖的相关性和预测价值
Sci Rep. 2024 Dec 30;14(1):31776. doi: 10.1038/s41598-024-82751-7.
4
Low skeletal muscle mass is associated with insulin resistance, diabetes, and metabolic syndrome in the Korean population: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2010.在韩国人群中,低骨骼肌质量与胰岛素抵抗、糖尿病和代谢综合征相关:2009 - 2010年韩国国家健康与营养检查调查(KNHANES)
Endocr J. 2014;61(1):61-70. doi: 10.1507/endocrj.ej13-0244. Epub 2013 Oct 1.
5
Sarcopenia is associated with albuminuria independently of hypertension and diabetes: KNHANES 2008-2011.肌肉减少症与白蛋白尿有关,与高血压和糖尿病无关:2008-2011 年韩国国家健康营养调查。
Metabolism. 2016 Oct;65(10):1531-40. doi: 10.1016/j.metabol.2016.07.003. Epub 2016 Jul 8.
6
Sarcopenia risk in U.S. younger adults: the impact of physical activity intensity and occupational engagement-insights from a cross-sectional NHANES study.美国年轻成年人的肌肉减少症风险:体力活动强度和职业参与的影响——来自 NHANES 横断面研究的见解。
BMC Public Health. 2024 Nov 14;24(1):3179. doi: 10.1186/s12889-024-20665-9.
7
Higher Risk of Sarcopenia in Older Adults with Type 2 Diabetes: NHANES 1999-2018.2 型糖尿病老年患者发生肌肉减少症的风险更高:NHANES 1999-2018。
Obes Facts. 2023;16(3):237-248. doi: 10.1159/000530241. Epub 2023 Apr 3.
8
The association between body roundness index and sarcopenia in older adults: a population-based study.老年人身体圆润度指数与肌肉减少症之间的关联:一项基于人群的研究。
Front Public Health. 2025 Apr 4;13:1554491. doi: 10.3389/fpubh.2025.1554491. eCollection 2025.
9
The Relationship between physical activity, nutritional status, and sarcopenia in community- dwelling older adults with type 2 diabetes: a cross-sectional study.社区 2 型糖尿病老年患者体力活动、营养状况与肌肉减少症的关系:一项横断面研究。
BMC Geriatr. 2024 Jun 7;24(1):506. doi: 10.1186/s12877-024-05038-6.
10
The Role of Sarcopenia in Overactive Bladder in Adults in the United States: Retrospective Analysis of NHANES 2011-2018.美国成年人中肌少症在膀胱过度活动症中的作用:NHANES 2011-2018 的回顾性分析。
J Nutr Health Aging. 2023;27(9):734-740. doi: 10.1007/s12603-023-1972-3.

本文引用的文献

1
Associations of muscle mass, strength, and quality with diabetes and the mediating role of inflammation in two National surveys from China and the United states.肌肉量、力量和质量与糖尿病的关联,以及炎症在中国和美国的两项全国性调查中的中介作用。
Diabetes Res Clin Pract. 2024 Aug;214:111783. doi: 10.1016/j.diabres.2024.111783. Epub 2024 Jul 11.
2
Type 2 Diabetes Mellitus and Sarcopenia as Comorbid Chronic Diseases in Older Adults: Established and Emerging Treatments and Therapies.2 型糖尿病和老年人肌少症作为共病的慢性疾病:已确立和新兴的治疗方法和疗法。
Diabetes Metab J. 2023 Nov;47(6):719-742. doi: 10.4093/dmj.2023.0112. Epub 2023 Sep 14.
3
Diet, exercise, and pharmacotherapy for sarcopenia in people with diabetes.
饮食、运动和药物治疗对糖尿病患者的肌少症的影响。
Metabolism. 2023 Jul;144:155585. doi: 10.1016/j.metabol.2023.155585. Epub 2023 May 6.
4
Web Exclusive. Annals On Call - First-Line Drug Therapy for Type 2 Diabetes.网络独家。《医学年鉴》随叫随到——2型糖尿病的一线药物治疗
Ann Intern Med. 2023 Feb;176(2):eA220004. doi: 10.7326/A22-0004.
5
Spatial proteomics in three-dimensional intact specimens.三维完整标本中的空间蛋白质组学。
Cell. 2022 Dec 22;185(26):5040-5058.e19. doi: 10.1016/j.cell.2022.11.021.
6
2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023.2. 糖尿病的分类和诊断:2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S19-S40. doi: 10.2337/dc23-S002.
7
Diabetic kidney disease in pediatric patients: A current review.儿科患者的糖尿病肾病:当前综述
World J Diabetes. 2022 Aug 15;13(8):587-599. doi: 10.4239/wjd.v13.i8.587.
8
Therapeutic Benefits and Dietary Restrictions of Fiber Intake: A State of the Art Review.膳食纤维的治疗益处和饮食限制:综述。
Nutrients. 2022 Jun 26;14(13):2641. doi: 10.3390/nu14132641.
9
Sense and Learn: Recent Advances in Wearable Sensing and Machine Learning for Blood Glucose Monitoring and Trend-Detection.感知与学习:可穿戴传感与机器学习在血糖监测和趋势检测方面的最新进展
Front Bioeng Biotechnol. 2022 May 12;10:876672. doi: 10.3389/fbioe.2022.876672. eCollection 2022.
10
IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.国际糖尿病联盟(IDF)糖尿病地图集:2021 年全球、区域和国家糖尿病患病率估算值以及 2045 年预测值。
Diabetes Res Clin Pract. 2022 Jan;183:109119. doi: 10.1016/j.diabres.2021.109119. Epub 2021 Dec 6.